New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Gas-releasing adjuvant improves efficacy of photothermal therapy for cancer

Gas-releasing adjuvant improves efficacy of photothermal therapy for cancer

byWileyA nanoplatform based on copper sulfide (ADT@CuSNDs) that is able to remodel the tumor energy via hydrogen sulfide (H2S) mediation was developed to sensitize the tumor to mild photothermal
World medicine December 13,2023
Gas-releasing adjuvant improves efficacy of photothermal therapy for cancer

Gas-releasing adjuvant improves efficacy of photothermal therapy for cancer

byWileyA nanoplatform based on copper sulfide (ADT@CuSNDs) that is able to remodel the tumor energy via hydrogen sulfide (H2S) mediation was developed to sensitize the tumor to mild photothermal
World medicine December 13,2023
Umbilical cord white blood cells developed to advance cancer treatment

Umbilical cord white blood cells developed to advance cancer treatment

bySingHealth1. Expansion of leukemia targeting CBγδ.(A) Average (± SEM) fold expansion of CBγδover 21 days in REP cultures (n= 6). (B) CBγδsubtype composition before and after
World medicine December 13,2023
Umbilical cord white blood cells developed to advance cancer treatment

Umbilical cord white blood cells developed to advance cancer treatment

bySingHealth1. Expansion of leukemia targeting CBγδ.(A) Average (± SEM) fold expansion of CBγδover 21 days in REP cultures (n= 6). (B) CBγδsubtype composition before and after
World medicine December 13,2023
Research uncovers new path for melanoma detection and treatment

Research uncovers new path for melanoma detection and treatment

byEdith Cowan UniversityLead researcher from Edith Cowan University, Associate Professor Elin Gray. Credit: Edith Cowan UniversityA new way to spot melanoma cells circulating in the blood has th
World medicine December 13,2023
Research uncovers new path for melanoma detection and treatment

Research uncovers new path for melanoma detection and treatment

byEdith Cowan UniversityLead researcher from Edith Cowan University, Associate Professor Elin Gray. Credit: Edith Cowan UniversityA new way to spot melanoma cells circulating in the blood has th
World medicine December 13,2023
New technique predicts which melanoma patients are at risk for cancer recurrence, spread

New technique predicts which melanoma patients are at risk for cancer recurrence, spread

byBrigham and Women's HospitalScanning electron micrograph of human T lymphocyte or T cell. Credit: NIAID/NIHFor most patients, melanoma begins with a small, pigmented spot on their skin tha
World medicine December 13,2023
New technique predicts which melanoma patients are at risk for cancer recurrence, spread

New technique predicts which melanoma patients are at risk for cancer recurrence, spread

byBrigham and Women's HospitalScanning electron micrograph of human T lymphocyte or T cell. Credit: NIAID/NIHFor most patients, melanoma begins with a small, pigmented spot on their skin tha
World medicine December 13,2023
Common blood thinner may double as cancer therapy

Common blood thinner may double as cancer therapy

byColumbia University Irving Medical CenterCredit:Cell Metabolism(2023). DOI: 10.1016/j.cmet.2023.06.014Warfarin, a widely used blood thinner, appears to have potent anti-cancer prop
World medicine December 13,2023
Common blood thinner may double as cancer therapy

Common blood thinner may double as cancer therapy

byColumbia University Irving Medical CenterCredit:Cell Metabolism(2023). DOI: 10.1016/j.cmet.2023.06.014Warfarin, a widely used blood thinner, appears to have potent anti-cancer prop
World medicine December 13,2023
Targeting turncoat immune cells to treat cancer

Targeting turncoat immune cells to treat cancer

byLudwig Institute for Cancer ResearchPing-Chih Ho, associate member of the Lausanne Branch of the Ludwig Institute for Cancer Research. Credit: Ludwig Cancer ResearchA Ludwig Cancer Research st
World medicine December 13,2023
Targeting turncoat immune cells to treat cancer

Targeting turncoat immune cells to treat cancer

byLudwig Institute for Cancer ResearchPing-Chih Ho, associate member of the Lausanne Branch of the Ludwig Institute for Cancer Research. Credit: Ludwig Cancer ResearchA Ludwig Cancer Research st
World medicine December 13,2023
Protein AKAP8 suppresses breast cancer metastasis

Protein AKAP8 suppresses breast cancer metastasis

by Molly Chiu,Baylor College of MedicineCredit: CC0 Public DomainA protein naturally produced in the body has been found to suppress breast cancer metastasis in animal models of human tumors. Re
World medicine December 13,2023
Protein AKAP8 suppresses breast cancer metastasis

Protein AKAP8 suppresses breast cancer metastasis

by Molly Chiu,Baylor College of MedicineCredit: CC0 Public DomainA protein naturally produced in the body has been found to suppress breast cancer metastasis in animal models of human tumors. Re
World medicine December 13,2023
Evaluating cetuximab's effectiveness and toxicity in advanced cutaneous squamous cell skin cancer

Evaluating cetuximab's effectiveness and toxicity in advanced cutaneous squamous cell skin cancer

by Impact Journals LLCProgression-free survival of all 18 patients. Censored patients are indicated by hash marks. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28470A new research pap
World medicine December 13,2023
Evaluating cetuximab's effectiveness and toxicity in advanced cutaneous squamous cell skin cancer

Evaluating cetuximab's effectiveness and toxicity in advanced cutaneous squamous cell skin cancer

by Impact Journals LLCProgression-free survival of all 18 patients. Censored patients are indicated by hash marks. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28470A new research pap
World medicine December 13,2023
'Chromosome shattering': Understanding chromothripsis in human cancer

'Chromosome shattering': Understanding chromothripsis in human cancer

by Vicky Hatch,European Molecular Biology LaboratoryArtist's impression of chromothripsis. Credit: Spencer Phillips/EMBL-EBIResearchers at Harvard Medical School and EMBL-EBI have carried ou
World medicine December 13,2023
'Chromosome shattering': Understanding chromothripsis in human cancer

'Chromosome shattering': Understanding chromothripsis in human cancer

by Vicky Hatch,European Molecular Biology LaboratoryArtist's impression of chromothripsis. Credit: Spencer Phillips/EMBL-EBIResearchers at Harvard Medical School and EMBL-EBI have carried ou
World medicine December 13,2023
Facebook postings by breast cancer patients initially surge, then decline over time

Facebook postings by breast cancer patients initially surge, then decline over time

byUniversity of MinnesotaCredit: RidofranzTransitions in breast cancer care are associated with significant increases in stress and anxiety, and this stress can negatively impact the mental and
World medicine December 13,2023
Facebook postings by breast cancer patients initially surge, then decline over time

Facebook postings by breast cancer patients initially surge, then decline over time

byUniversity of MinnesotaCredit: RidofranzTransitions in breast cancer care are associated with significant increases in stress and anxiety, and this stress can negatively impact the mental and
World medicine December 13,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com